The Modernization of Cosmetics Registration Act of 2022 (MoCRA) introduces significant regulatory changes to the U.S. cosmetic industry, marking the first major expansion of FDA authority since 1938. Key points include:
-
Adverse Event Reporting: By Dec. 29, 2024, cosmetic product labels must include contact information (electronic or physical) for reporting adverse reactions. This aims to improve accountability, consumer safety, and regulatory oversight.
-
Professional Use Labeling: Products intended for professionals must now be clearly labeled, ensuring proper use and safety.
-
Regulation Drivers: The lack of prior oversight, widespread state-level regulations, and a growing $500 billion cosmetic industry prompted the need for federal regulation.
-
Focus on Skin Care and Perfumes: Skin care products, often lacking comprehensive safety testing, and perfumes, frequently counterfeited, are expected to face the most scrutiny under MoCRA.
-
Consumer Confidence: The regulations aim to reduce counterfeit cosmetics and ensure safety, offering consumers a clear process for addressing adverse events.
-
Dermatologists’ Role: Dermatologists can play a crucial role by reporting trends or recurring issues with specific products, helping the industry improve safety and effectiveness.
Jaclyn Bellomo highlights that MoCRA is long overdue, introducing much-needed transparency and confidence in the U.S. cosmetic market while creating challenges for brands unprepared for new compliance requirements.
Read the original article here.
Return to Publication Archive